公开(公告)号：US11801280B2

公开(公告)日：2023-10-31

申请号：US17415969

申请日：2020-04-08

申请人： HUBEI MONYAN PHARMACEUTICAL CO., LTD.

发明人： Min Zhang

IPC分类号： A61K36/899 ,  A61K9/08 ,  A61K36/232 ,  A61K36/296 ,  A61K36/48 ,  A61K36/481 ,  A61K36/484 ,  A61K36/487 ,  A61K36/714 ,  A61K36/74 ,  A61K36/77 ,  A61K36/8968 ,  A61K9/00

CPC分类号： A61K36/899 ,  A61K9/0053 ,  A61K9/08 ,  A61K36/232 ,  A61K36/296 ,  A61K36/48 ,  A61K36/481 ,  A61K36/484 ,  A61K36/487 ,  A61K36/714 ,  A61K36/74 ,  A61K36/77 ,  A61K36/8968 ,  A61K2236/331 ,  A61K2236/333 ,  A61K2236/37 ,  A61K2236/51

摘要： The present invention relates to a drug for treating leukopenia, its preparation method and use thereof. The drug of the invention is prepared from 200-30 parts by weight of Folium Epimedii, 100-160 parts by weight of Fructus Psoraleae, 60-120 parts by weight of Radix Aconiti Lateralis Preparata (Processed), 200-300 parts by weight of Fructus Lycii, 200-300 parts by weight of Radix Astragali, 200-300 parts by weight of Caulis Spatholobi, 200-300 parts by weight of Radix Rubiae, 100-160 parts by weight of Radix Angelicae Sinensis, 200-300 parts by weight of Rhizoma Phragmitis, 100-160 parts by weight of Radix Ophiopogonis and 100-160 parts by weight of Radix et Rhizoma Glycyrrhizae. The drug of the invention comprises chemical substances with weight ratios as follows: Leucine:guanosine:psoralenoside:isopsoralenoside:calycosin-7-glucoside:liquiritin:icariin A:1,3-dihydroxyl-2-hydroxymethylanthraquinone:epimedin A:epimedin B:epimedin C:icariin:1,3,6-trihydroxy-2-methylanthraquinone:glycyrrhizic acid=(0.13-0.27):(0.04-0.11):(0.11-0.34):(0.09-0.34):(0.05-0.11):(0.16-0.26):(0.09-0.12):(0.17-0.35):(0.11-0.16):(0.17-0.26):(0.49-0.59):1.00:(0.16-0.24):(0.08-0.14).